论文部分内容阅读
传统大佬进入医药电商已经失去了先发优势,但十年发展下来,医药电商的格局仍未清晰,2015年更将进入混战时期,这是传统大佬的机会,也很可能是最后一次机会。进入2014年,医药零售业为数不多的几家上市公司,都宣告进军医药电商:一心堂发布《电商业务发展规划》,未来两年计划投资1.2亿元发展医药电商,涉及电商、CRM项目、物流系统升级等多个项目建设;嘉事堂对零售板块进行增资扩股,连锁药店
Traditional bigwigs into the medical e-commerce has lost its first mover advantage, but the development of the decade, the e-commerce pattern is still not clear, in 2015 will enter the melee, which is the opportunity of the traditional big brother, and may also be the last a chance. In 2014, a few listed pharmaceutical companies in the pharmaceutical retail industry announced that they will enter the pharmaceutical e-commerce business: Yishitang publishes the “E-commerce Business Development Plan” and plans to invest 120 million yuan in the next two years to develop pharmaceutical e-commerce businesses involving e-commerce , CRM projects, logistics system upgrades and other projects; Chia-ching Tong, the retail sector to increase their investment, chain pharmacies